Investors / China / MSA Capital
MSA Capital
Venture capital · Beijing, China · Asia Pacific
MSA Capital is a global investment firm founded in 2014 that focuses on private venture and growth assets. It manages over USD 2 billion and invests in biotechnology and enterprise-facing core technology companies.
Invests inHealthcare & BiotechFintech
In its own wordsbiotechnologyenterprise technologylife scienceshealthcaregrowthventure
Your fit with MSA Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMSA Capital lists 28 checked portfolio companies on its own site and is named in 3 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 67% of the companies with a known first round. Its largest themes are Healthcare & Biotech (23%), Fintech (20%) and Consumer (9%). 57% of its companies are based in China. It invests most often alongside FreeS Fund, Qiming Venture Partners and Sentinel Global.
Counts come from funding rounds that name MSA Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not MSA Capital's whole history. Rounds on record name 3 companies; its own site lists 28. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 33% |
| Series A | 67% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 1 | 1 |
| '22 | 1 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 64th | 27 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 64th | 33% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 27th | 23% in its largest sector |
| Reach | 84th | 6 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 23% | 15% |
| Fintech | 20% | 12% |
| Consumer | 9% | 3% |
| Food & Agriculture | 9% | 3% |
| AI & Machine Learning | 9% | 18% |
| E-commerce & Marketplaces | 9% | 6% |
| Real Estate & Construction | 6% | 3% |
| Robotics & Hardware | 3% | 1% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| FreeS Fund | 3 |
| Qiming Venture Partners | 3 |
| Sentinel Global | 3 |
| SoftBank Vision Fund | 3 |
| Andreessen Horowitz | 2 |
| General Atlantic | 2 |
| Global Ventures | 2 |
| HSG | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2796%
- No longer answers00%
- Points to another company14%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare MSA Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with MSA Capital| Date | Company | Stage |
|---|---|---|
| 17 Feb 2026 | Series A | |
| 6 Jan 2022 | Series A | |
| 3 Aug 2021 | Seed Led |
Round details for MSA Capital
Amounts, full round histories and every co-investor in MSA Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
28 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abogen Biosciences develops medicines through RNA innovations | Healthcare & Biotech | Portfolio page | ||
| The company provides a platform for booking vacation rentals and experiences. | Real Estate & ConstructionLegal & Compliance | Portfolio page | ||
| Anxuyuan Biotechnology develops and produces gene sequencing platforms, molecular diagnostic platforms, and corresponding reagent products | Healthcare & Biotech | Portfolio page | ||
ConsumerConsumer | Portfolio page | |||
| The company provides AI for science solutions and services, including software and research tools, to scientists and research organizations. | AI & Machine LearningHealthcare & Biotech | Portfolio page | ||
| Fabu develops and provides AI-based software and hardware systems for industries to improve production safety and efficiency | AI & Machine LearningIndustrial & Manufacturing | Portfolio page | ||
| Flextock provides fulfillment solutions for businesses, including end-to-end fulfillment, delivery aggregation, and sales growth services. | E-commerce & MarketplacesFintech | Feb 2026Series A | Funding round | |
| Fore Coffee is a startup that makes specialty coffee for customers | Food & Agriculture | Portfolio page | ||
| Portfolio page | ||||
| Goldfinch Finance provides access to private credit funds on a blockchain platform. | FintechFintech | Jan 2022Series A | Funding round | |
| Kitopi operates cloud kitchens, restaurants, and food delivery services. | Food & Agriculture | Portfolio page | ||
| The company operates in the food industry, specifically in the retail and e-commerce of traditional Sichuan cuisine products, including instant noodles and other dishes. | Food & Agriculture | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Nubank provides financial services including credit cards, accounts, and loans. | FintechFintech | Portfolio page | ||
| Pyrotech Therapeutics treats human diseases through precision modulation of innate immunity. | Healthcare & Biotech | Portfolio page | ||
| Cider sells women's fashion clothing. | Consumer | Portfolio page | ||
| The company provides single cell sequencing solutions and products | Healthcare & Biotech | Portfolio page | ||
| Sironax is committed to bringing new treatments to patients by targeting the underlying contributors of degeneration, including disrupted energy homeostatis, dysregulated cell death, and uncontrolled inflammation, across various organs and tissues. | Healthcare & Biotech | Portfolio page | ||
| Tabby provides financial services including spending, sending, saving, and payment plans through its app and cards. | FintechE-commerce & Marketplaces | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- msacap.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 3 Aug 2021
- Companies checked
- 28
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get MSA Capital's profile as data
Pull MSA Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/msacap.com
# also
GET /v1/firms/msacap.com/portfolio
GET /v1/firms/msacap.com/coinvestors
GET /v1/firms/msacap.com/news